Dallah Healthcare Company SJSC
SAU:4004

Watchlist Manager
Dallah Healthcare Company SJSC Logo
Dallah Healthcare Company SJSC
SAU:4004
Watchlist
Price: 162.2 SAR 0.12% Market Closed
Market Cap: 15.8B SAR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
Dallah Healthcare Company SJSC

Wall Street analysts forecast Dallah Healthcare Company SJSC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dallah Healthcare Company SJSC is 166.62 SAR with a low forecast of 138.37 SAR and a high forecast of 192.15 SAR.

Lowest Forecast
Wall Street Target
138.37 SAR
15% Downside
Average Forecast
Wall Street Target
166.62 SAR
3% Upside
Highest Forecast
Wall Street Target
192.15 SAR
18% Upside
Lowest
Price Target
138.37 SAR
15% Downside
Average
Price Target
166.62 SAR
3% Upside
Highest
Price Target
192.15 SAR
18% Upside
Dallah Healthcare Company SJSC Competitors:
Price Targets
R
RPH
Ratchaphruek Hospital PCL
22% Upside
A
4007
Al Hammadi Holding Co
19% Upside
K
KPJ
KPJ Healthcare Bhd
11% Upside
R
RAINBOW
Rainbow Children's Medicare Ltd
8% Upside
R
RPH
Ratchaphruek Hospital PCL
22% Upside
A
4007
Al Hammadi Holding Co
19% Upside
K
KPJ
KPJ Healthcare Bhd
11% Upside
R
RAINBOW
Rainbow Children's Medicare Ltd
8% Upside
SILO
Siloam International Hospitals Tbk PT
52% Upside
I
IHH
IHH Healthcare Bhd
24% Upside
A
300015
Aier Eye Hospital Group Co Ltd
14% Upside
USPH
US Physical Therapy Inc
59% Upside

Revenue
Forecast

Revenue Estimate
Dallah Healthcare Company SJSC

For the last 8 years the compound annual growth rate for Dallah Healthcare Company SJSC's revenue is 14%. The projected CAGR for the next 2 years is 16%.

14%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Dallah Healthcare Company SJSC

For the last 8 years the compound annual growth rate for Dallah Healthcare Company SJSC's operating income is 12%. The projected CAGR for the next 3 years is 19%.

12%
Past Growth
19%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Dallah Healthcare Company SJSC

For the last 8 years the compound annual growth rate for Dallah Healthcare Company SJSC's net income is 10%. The projected CAGR for the next 3 years is 17%.

10%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Dallah Healthcare Company SJSC's stock price target?
Price Target
166.62 SAR

According to Wall Street analysts, the average 1-year price target for Dallah Healthcare Company SJSC is 166.62 SAR with a low forecast of 138.37 SAR and a high forecast of 192.15 SAR.

What is Dallah Healthcare Company SJSC's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Dallah Healthcare Company SJSC's revenue is 14%. The projected CAGR for the next 2 years is 16%.

What is Dallah Healthcare Company SJSC's Operating Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Dallah Healthcare Company SJSC's operating income is 12%. The projected CAGR for the next 3 years is 19%.

What is Dallah Healthcare Company SJSC's Net Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Dallah Healthcare Company SJSC's net income is 10%. The projected CAGR for the next 3 years is 17%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 246,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.